Influenza vaccine
AssigneeDenka Company Limited
InventorsRyotaro MITSUMATA, Tomohiro NARAHARA
Life of this patent
Estimating the term…
Abstract
An influenza vaccine that has high immunogenicity in children and elderly people and has a higher efficacy than conventional split vaccines. An influenza vaccine composition to be administered to children and/or elderly people, including, as a virus antigen, inactivated whole particles subjected to inactivation treatment with beta-propiolactone.
Claims6
An influenza vaccine composition to be administered to children and/or elderly people, comprising, as a virus antigen, inactivated whole particles subjected to inactivation treatment with beta-propiolactone.
An immunization method comprising administering a composition containing, as a virus antigen, inactivated whole particles subjected to inactivation treatment with beta-propiolactone to children or elderly people.
An influenza prevention method comprising administering a composition containing, as a virus antigen, inactivated whole particles subjected to inactivation treatment with beta-propiolactone to children or elderly people.
Dependencies are inferred from the claim text.